These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38878809)

  • 1. Unmet Need: Mechanistic and Translational Studies of Sickle Cell Disease Pain as a Whole-Person Health Challenge.
    Belfer I; Chen W; Weber W; Edwards E; Langevin HM
    J Pain; 2024 Oct; 25(10):104603. PubMed ID: 38878809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain in sickle cell disease: current and potential translational therapies.
    Sagi V; Mittal A; Tran H; Gupta K
    Transl Res; 2021 Aug; 234():141-158. PubMed ID: 33711512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathic Pain and Sickle Cell Disease: a Review of Pharmacologic Management.
    Orhurhu MS; Chu R; Claus L; Roberts J; Salisu B; Urits I; Orhurhu E; Viswanath O; Kaye AD; Kaye AJ; Orhurhu V
    Curr Pain Headache Rep; 2020 Jul; 24(9):52. PubMed ID: 32705357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
    Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting novel mechanisms of pain in sickle cell disease.
    Tran H; Gupta M; Gupta K
    Blood; 2017 Nov; 130(22):2377-2385. PubMed ID: 29187376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
    Puri L; Nottage KA; Hankins JS; Anghelescu DL
    Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting novel mechanisms of pain in sickle cell disease.
    Tran H; Gupta M; Gupta K
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):546-555. PubMed ID: 29222304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle Cell Disease: A Review.
    Kavanagh PL; Fasipe TA; Wun T
    JAMA; 2022 Jul; 328(1):57-68. PubMed ID: 35788790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic pain management in patients with sickle cell disease in the modern era: a comprehensive review.
    Tolu SS; Van Doren L
    Transfus Apher Sci; 2022 Oct; 61(5):103533. PubMed ID: 36058780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathic pain in sickle cell disease: measurement and management.
    Glaros A; Brandow AM
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):553-561. PubMed ID: 33275730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic methods to advance mechanistic understanding and translational research in sickle cell disease.
    Azul M; Vital EF; Lam WA; Wood DK; Beckman JD
    Transl Res; 2022 Aug; 246():1-14. PubMed ID: 35354090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crises in Sickle Cell Disease.
    Novelli EM; Gladwin MT
    Chest; 2016 Apr; 149(4):1082-93. PubMed ID: 26836899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathic pain in individuals with sickle cell disease.
    Sharma D; Brandow AM
    Neurosci Lett; 2020 Jan; 714():134445. PubMed ID: 31454562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse Models of Pain in Sickle Cell Disease.
    Sagi V; Song-Naba WL; Benson BA; Joshi SS; Gupta K
    Curr Protoc Neurosci; 2018 Oct; 85(1):e54. PubMed ID: 30265442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell disease pain management and the medical home.
    Raphael JL; Oyeku SO
    Hematology Am Soc Hematol Educ Program; 2013; 2013():433-8. PubMed ID: 24319216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review/overview of pain in sickle cell disease.
    Ballas SK; Darbari DS
    Complement Ther Med; 2020 Mar; 49():102327. PubMed ID: 32147066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An outpatient pain plan and ED pain pathway for adults with sickle cell disease.
    Mercado SH
    JAAPA; 2023 Mar; 36(3):20-23. PubMed ID: 36752670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and facilitators to care for individuals with sickle cell disease in central North Carolina: The emergency department providers' perspective.
    Masese RV; Bulgin D; Douglas C; Shah N; Tanabe P
    PLoS One; 2019; 14(5):e0216414. PubMed ID: 31063506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease.
    Taylor LE; Stotts NA; Humphreys J; Treadwell MJ; Miaskowski C
    J Pain Symptom Manage; 2010 Sep; 40(3):416-35. PubMed ID: 20656451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickle cell disease: a review for the internist.
    Pinto VM; Balocco M; Quintino S; Forni GL
    Intern Emerg Med; 2019 Oct; 14(7):1051-1064. PubMed ID: 31385153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.